ALPHARETTA, Ga., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical (CLSD), Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
Although there’s no cure for wet macular degeneration, treatments can slow the disease and prevent your eyesight from getting worse. If you start treatment early enough, you might be able to regain ...
A phase III trial found that the sustained-release VEGF inhibitor implant OTX-TKI preserved visual acuity and retinal anatomy in wet age-related macular degeneration better than standard aflibercept ...
Both anti-VEGF and surgical treatments improve VA in AMD-related submacular hemorrhage, with no statistically significant difference between the two treatments. Anti-VEGF injections may be associated ...
REDWOOD CITY, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, ...
Wet age-related macular degeneration (AMD) is an eye condition that threatens the middle of your eyesight. It’s caused when abnormal blood vessels in your eyes leak fluid, damaging the part of your ...
Please provide your email address to receive an email when new articles are posted on . Researchers linked higher frequency of intravitreal anti-VEGF injections with a greater risk for mild cognitive ...
Injection-free subgroup results demonstrated that a single intravitreal dose of 4D-150 without any supplemental anti-VEGF injections resulted in stable mean visual acuity that was equal to or higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results